We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+21.8%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$1.25B
AUM Growth
+$211M
Cap. Flow
-$1.73M
Cap. Flow %
-0.14%
Top 10 Hldgs %
90.34%
Holding
52
New
1
Increased
2
Reduced
9
Closed

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.43M
2
LLY icon
Eli Lilly
LLY
+$1.92M
3
MSFT icon
Microsoft
MSFT
+$427K

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$5.19M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.5M
3
PFE icon
Pfizer
PFE
+$1.37M
4
ZTS icon
Zoetis
ZTS
+$250K
5
WSM icon
Williams-Sonoma
WSM
+$169K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 64.1%
2 Healthcare 22.43%
3 Technology 6.6%
4 Consumer Staples 1.96%
5 Financials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$29.5B
$796M 63.77%
7,891,640
-1,954
-0% -$169K
LLY icon
2
Eli Lilly
LLY
$1.08T
$86.5M 6.93%
148,423
+3,290
+2% +$1.92M
AAPL icon
3
Apple
AAPL
$4.45T
$50.3M 4.03%
261,400
ABBV icon
4
AbbVie
ABBV
$442B
$38.8M 3.11%
250,660
ABT icon
5
Abbott
ABT
$190B
$32.8M 2.63%
298,230
ZTS icon
6
Zoetis
ZTS
$31.1B
$29.1M 2.33%
147,499
-1,415
-1% -$250K
MSFT icon
7
Microsoft
MSFT
$3.74T
$27.1M 2.17%
72,050
+1,200
+2% +$427K
JNJ icon
8
Johnson & Johnson
JNJ
$626B
$25.3M 2.02%
161,232
MRK icon
9
Merck
MRK
$322B
$22.7M 1.82%
208,500
BMY icon
10
Bristol-Myers Squibb
BMY
$130B
$19M 1.53%
371,264
-28,600
-7% -$1.5M
CAT icon
11
Caterpillar
CAT
$388B
$17.7M 1.42%
60,000
KVUE icon
12
Kenvue
KVUE
$36.6B
$10.3M 0.82%
477,887
-259,211
-35% -$5.19M
ZBH icon
13
Zimmer Biomet
ZBH
$18.5B
$10.1M 0.81%
82,950
DIS icon
14
Walt Disney
DIS
$179B
$9.16M 0.73%
101,500
MA icon
15
Mastercard
MA
$492B
$8.53M 0.68%
20,000
PFE icon
16
Pfizer
PFE
$152B
$7.92M 0.63%
275,101
-45,200
-14% -$1.37M
BRK.B icon
17
Berkshire Hathaway Class B
BRK.B
$1.11T
$7.58M 0.61%
21,244
-4
-0% -$1.4K
PG icon
18
Procter & Gamble
PG
$338B
$6.58M 0.53%
44,871
KMB icon
19
Kimberly-Clark
KMB
$36.1B
$6.56M 0.53%
54,000
CI icon
20
Cigna
CI
$72.4B
$6.52M 0.52%
21,779
NVDA icon
21
NVIDIA
NVDA
$5.27T
$4.73M 0.38%
+95,500
New +$4.43M
BRK.A icon
22
Berkshire Hathaway Class A
BRK.A
$1.11T
$3.26M 0.26%
6
AMZN icon
23
Amazon
AMZN
$2.94T
$3.05M 0.24%
20,100
EPD icon
24
Enterprise Products Partners
EPD
$81.8B
$2.86M 0.23%
108,704
GOOG icon
25
Alphabet (Google) Class C
GOOG
$4.19T
$2.49M 0.2%
17,660

Similar funds

Blackhill Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Blackhill Capital held 52 positions worth $1.25B, up 20% from $1.04B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 1.9%. Blackhill Capital opened 1 new position and made no exits, leaving the 52-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 64% of assets, up from 59% a quarter earlier, followed by Healthcare and Technology.

  • Blackhill Capital's largest Q4 2023 buy was NVIDIA: 95,500 shares worth $4.73M.
  • Blackhill Capital added most to Eli Lilly in Q4 2023, an estimated $1.92M increase.
  • Blackhill Capital's biggest Q4 2023 reduction was Kenvue, cutting an estimated $5.19M.
  • Blackhill Capital's ten largest holdings make up 90% of its $1.25B portfolio in Q4 2023.
  • Blackhill Capital opened 1 new position and closed 0 in Q4 2023.
  • Blackhill Capital's portfolio value rose 20% quarter-over-quarter to $1.25B.

Based on Blackhill Capital's 13F filing for Q4 2023, filed 12 Feb 2024.